BCLC 2025 Guidelines introduce a new model to personalize liver cancer treatment
The Barcelona Clínic Liver Cancer (BCLC) group, within the framework of the Clínic Barcelona Comprehensive Cancer Center —a center promoted by Clínic1
The Barcelona Clínic Liver Cancer (BCLC) group, within the framework of the Clínic Barcelona Comprehensive Cancer Center —a center promoted by Clínic1
IDIBAPS launched the first call of DYNAMIS (Doctoral programme Yielding Novel Advancements in Medicine and Innovative Solutions). This IDIBAPS scheme1
An international controlled clinical study published in The New England Journal of Medicine demonstrates that liquid biopsy can help identify which p1
Two studies led by the IDIBAPS Liver Vascular Biology group, headed by Jordi Gracia-Sancho, reveal the key role of miRNAs in hepatic endothelial dysf1
A team from Hospital Clínic-IDIBAPS has identified changes in brain connectivity in women who have recently experienced sexual assault and developed1
A team from the Clínic-IDIBAPS has led a study of the international consortium of neuroimage ENIGMA that has allowed us a better understanding o1
Chronic hepatitis B virus (HBV) infection remains a significant global health concern, affecting an estimated 254 million people worldwide and contri1
The Ministry of Science, Innovation and Universities announced this Friday the winners of the 2025 National Research Awards, one of the most prestigi1
An IDIBAPS team identifies a molecular interaction that drives the aggressiveness of lymphoma and proposes a new therapeutic strategy 1
"La Caixa" Foundation will allocate €150,000 to the project led by Alba Rodríguez, from the IDIBAPS Cellular Immunotherapies for Cancer research grou1